Immunoglobulin A Nephropathy (IgAN): Clinical Trials

1 trial for Immunoglobulin A Nephropathy (IgAN), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Immunoglobulin A Nephropathy (IgAN): new trials by email Literature Review of Immunoglobulin A Nephropathy (IgAN) trials Research Report on Immunoglobulin A Nephropathy (IgAN)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN)
atrasentan - IgA Nephropathy (IgAN), Immunoglobulin A Nephropathy (IgAN)
Phase 4Not yet recruitingUniversity of Illinois at Chicago202026-09-292026-09-21

Narrower conditions

Fibrosis (1)  ·  Glomerulonephritis, IGA (1)

Broader conditions

Autoimmune Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Immune System Diseases (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Atrasentan (1)

Sponsors

University of Illinois at Chicago (1)

Countries

United States (1)

Top investigators

Anand Srivastava, MD, MPH (1)